Power of Attorney for Yue Xiong

This filing details a Power of Attorney granted by Yue Xiong, Chief Scientific Officer of Gyre Therapeutics, Inc., to Ying Luo, Thomas Eastling, and Joshua Bergmann. This authorization allows the appointed attorneys-in-fact to prepare and execute necessary SEC filings, including Forms 3, 4, and 5, on behalf of Ms. Xiong. These filings are required under Section 16(a) of the Securities Exchange Act of 1934, related to her holdings and transactions in the company's securities. The Power of Attorney also covers obtaining electronic filing credentials and performing any other actions deemed beneficial or legally required. It remains in effect until Ms. Xiong is no longer obligated to file these forms, unless earlier revoked. The filing also notes that as of May 4, 2026, Ms. Xiong received Series B Preferred Stock in a merger involving Cullgen Inc., which is convertible into common stock subject to beneficial ownership limitations.